Market cap
₹10 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
455.2
P/B Ratio
0.7
Div. Yield
0 %
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
10 | 48,818 | 17,538 | 7,959 | 1,735 |
Revenue (₹ Cr) |
0 | 6,725 | 1,997 | 7,229 | 441 |
Net Profit (₹ Cr) |
0.02 | 1,128.79 | 307.01 | 210.43 | 11.10 |
Net Margin (%) |
5.20 | 16.02 | 14.56 | 2.88 | 2.37 |
RoE (%) |
0.15 | 11.51 | 10.63 | 11.02 | 1.88 |
Price to Earnings |
455.15 | 43.25 | 55.66 | 37.82 | 156.33 |
Price-To-Book |
0.70 | 4.59 | 5.51 | 3.98 | 2.74 |
Income Statement (₹ Cr)
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.39 | 6,430.65 | 1,875.26 | 6,892.47 | 392.41 |
|
Total Income
|
0.39 | 6,746.98 | 2,002.19 | 6,963.79 | 408.37 |
|
Total Expenditure
|
0.22 | 4,801.11 | 1,436.66 | 6,268.09 | 281.53 |
|
EBITDA
|
0.17 | 1,629.54 | 438.59 | 624.38 | 110.88 |
|
Depreciation
|
0.14 | 423.67 | 115.52 | 282.87 | 62.50 |
|
EBIT
|
0.03 | 1,205.88 | 323.08 | 341.51 | 48.38 |
|
Interest
|
0.00 | 33.28 | 21.42 | 137.50 | 19.54 |
|
Other Income
|
0.00 | 316.33 | 126.93 | 71.32 | 15.96 |
|
Exceptional Items
|
-- | -24.35 | -6.80 | -- | -- |
|
Profit before Tax
|
0.03 | 1,464.58 | 427.47 | 275.33 | 44.80 |
|
Provision for Tax
|
0.01 | 437.26 | 106.74 | 55.72 | 15.03 |
|
Profit after Tax
|
0.02 | 1,027.32 | 320.73 | 219.61 | 29.77 |
Liabilities (₹ Cr)
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
14.85 | 10,357.95 | 3,106.17 | 1,975.36 | 630.21 |
|
Minority Interest
|
-- | -- | 43.07 | -0.71 | -- |
|
Non-Current Liabilities
|
0.84 | 482.17 | 120.16 | 1,225.00 | 274.10 |
|
Current Liabilities
|
0.42 | 1,608.40 | 666.53 | 763.90 | 189.86 |
|
Total Liabilities
|
16.11 | 12,448.52 | 3,951.60 | 4,084.80 | 1,094.17 |
Assets (₹ Cr)
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
14.86 | 4,921.74 | 1,903.19 | 1,820.29 | 837.46 |
|
Current Assets
|
1.24 | 7,526.79 | 2,032.74 | 2,143.26 | 256.71 |
|
Total Assets
|
16.11 | 12,448.52 | 3,951.60 | 4,084.80 | 1,094.17 |
|
Total Debt*
|
0.00 | 243.36 | 341.62 | 0.00 | 328.56 |
|
Net Current Assets
|
0.83 | 5,918.38 | 1,366.21 | 1,379.36 | 66.85 |
|
Contingent Liabilities
|
0.08 | 10.12 | 50.21 | 14.06 | 1.20 |
Cashflow (₹ Cr)
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
0.89 | 1,031.39 | 246.37 | 495.58 | 114.24 |
|
Cash Flow from Investing Activities
|
-0.85 | 137.73 | -225.38 | -127.72 | -145.49 |
|
Cash from Financing Activities
|
0.85 | -416.97 | 20.15 | -255.51 | 38.95 |
|
Net Cash Inflow / Outflow
|
0.89 | 752.14 | 41.14 | 112.36 | 7.70 |
Ratios
Profitability Ratios
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.22 | 14.96 | 14.05 | 22.22 | 7.04 |
|
ROE (%)
|
0.16 | 10.56 | 10.94 | 11.93 | 4.79 |
|
ROA (%)
|
0.15 | 8.70 | 8.89 | 6.00 | 2.86 |
|
EBIT Margin (%)
|
44.87 | 30.26 | 30.16 | 10.09 | 32.32 |
|
Net Margin (%)
|
6.00 | 15.23 | 16.02 | 3.15 | 7.29 |
|
Cash Profit Margin (%)
|
42.58 | 22.56 | 23.12 | 7.19 | 23.51 |
Growth Ratios
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-1.70 | 14.50 | 12.30 | 12.33 | 32.40 |
|
EBIT Growth (%)
|
2.05 | 31.25 | 3.80 | 26.01 | 13.94 |
|
Net Profit Growth (%)
|
-1.67 | 47.07 | -5.27 | 46.18 | -30.18 |
|
EPS Growth (%)
|
-1.75 | 47.07 | -4.88 | 45.68 | -30.18 |
|
Book Value Growth (%)
|
0.16 | 12.70 | 12.14 | 14.76 | 2.83 |
Valuation Ratios
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Price / Earnings
|
295.98 | 27.22 | 37.47 | 45.79 | 53.92 |
|
Price / Book Value
|
0.47 | 2.71 | 3.90 | 5.11 | 2.55 |
|
Dividend Yield (%)
|
0.00 | 1.18 | 0.29 | 0.00 | 0.00 |
|
EV/EBITDA
|
33.13 | 12.77 | 21.79 | 13.79 | 15.04 |
|
Market Cap (₹ Cr)
|
6.96 | 27,964.97 | 12,069.92 | 10,057.49 | 1,605.21 |
Solvency Ratios
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.02 | 0.11 | 0.00 | 0.52 |
|
Short term debt to equity ratio
|
-- | -- | 0.08 | -- | 0.11 |
|
Current Ratio
|
2.98 | 4.68 | 3.05 | 2.81 | 1.35 |
|
Quick Ratio
|
2.98 | 3.60 | 2.40 | 1.00 | 0.69 |
|
Interest Coverage
|
36.00 | 45.01 | 20.96 | 3.00 | 3.29 |
Operating Efficiency Ratios
| Looks Health | Gland Pharma | Poly Medicure | Medplus Health | Tarsons Products | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
100.00 | 29.41 | 28.33 | 0.39 | 20.29 |
|
Asset Turnover
|
0.03 | 0.54 | 0.52 | 1.91 | 0.38 |
|
Receivable days
|
0.00 | 96.72 | 85.20 | 1.05 | 73.25 |
|
Inventory Days
|
0.00 | 97.32 | 69.58 | 71.25 | 118.49 |
|
Payable days
|
-- | 134.60 | 77.97 | 21.75 | 42.79 |
|
Cash Conversion Cycle
|
-- | 59.43 | 76.82 | 50.55 | 148.95 |